Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory
  2. Caputo, F; Mehn, D; Clogston,Jeffrey; Rösslein, M; Prina-Mello, A; Borgos, S E; Gioria, S; Calzolai, L
  3. Journal of chromatography. A. 2021, Jan 4; 1635: 461767.
  1. 2.   Molecular profiling of the human nasal epithelium: A proteomics approach
  2. Simoes, T.; Charro, N.; Blonder, J.; Faria, D.; Couto, F. M.; Chan, K. C.; Waybright, T.; Isaaq, H. J.; Veenstra, T. D.; Penque, D.
  3. Journal of Proteomics. 2011, Dec; 75(1): 56-69.
  1. 3.   Challenges in plasma membrane phosphoproteomics
  2. Orsburn, B. C.; Stockwin, L. H.; Newton, D. L.
  3. Expert Review of Proteomics. 2011, Aug; 8(4): 483-494.
  1. 4.   Identification and evaluation of soft coral diterpenes as inhibitors of HIF-2 alpha induced gene expression
  2. Grkovic, T.; Whitson, E. L.; Rabe, D. C.; Gardella, R. S.; Bottaro, D. P.; Linehan, W. M.; McMahon, J. B.; Gustafson, K. R.; McKee, T. C.
  3. Bioorganic & Medicinal Chemistry Letters. 2011, Apr; 21(7): 2113-2115.
  1. 5.   Characterization of the human ventricular cerebrospinal fluid proteome obtained from hydrocephalic patients
  2. Waybright, T.; Avellino, A. M.; Ellenbogen, R. G.; Hollinger, B. J.; Veenstra, T. D.; Morrison, R. S.
  3. Journal of Proteomics. 2010, Apr; 73(6): 1156-1162.
  1. 6.   Proteomic characterization of lipids rafts markers from the rat intestinal brush border
  2. Nguyen, H. T. T.; Amine, A. B.; Lafitte, D.; Waheed, A. A.; Nicoletti, C.; Villard, C.; Letisse, M.; Deyris, V.; Roziere, M.; Tchiakpe, L.; Danielle, C. D.; Comeau, L.; Hiol, A.
  3. Biochemical and Biophysical Research Communications. 2006, MAR 31; 342(1): 236-244.
  1. 7.   Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery
  2. Chertov, O.; Simpson, J. T.; Biragyn, A.; Conrads, T. P.; Veenstra, T. D.; Fisher, R. J.
  3. Expert Review of Proteomics. 2005, FEB; 2(1): 139-145.
  1. 8.   Umbelactonyl cinnamate derivatives from Crypteronia paniculata that mediate DNA strand scission
  2. Deng, J. Z.; Newman, D. J.; Hecht, S. M.
  3. Journal of Natural Products. 2005 68(3): 465-467.
  1. 9.   Investigation of the mouse serum proteome
  2. Hood, B. L.; Zhou, M.; Chan, K. C.; Lucas, D. A.; Kim, G. J.; Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.
  3. Journal of Proteome Research. 2005, SEP-OCT; 4(5): 1561-1568.
  1. 10.   A novel antimicrobial indolizinium alkaloid from Aniba panurensis
  2. Klausmeyer, P.; Chmurny, G. N.; McCloud, T. G.; Tucker, K. D.; Shoemaker, R. H.
  3. Journal of Natural Products. 2004, OCT; 67(10): 1732-1735.
  1. 11.   Global analysis of the cortical neuron proteome
  2. Yu, L. R.; Conrads, T. P.; Uo, T.; Kinoshita, Y.; Morrison, R. S.; Lucas, D. A.; Chan, K. C.; Blonder, J.; Issaq, H. J.; Veenstra, T. D.
  3. Molecular & Cellular Proteomics. 2004, SEP; 3(9): 896-907.
  1. 12.   Characterization and quantitation of membrane proteomes using multidimensional MS-based proteomic technologies
  2. Blonder, J.; Conrads, T. P.; Veenstra, T. D.
  3. Expert Review of Proteomics. 2004, AUG; 1(2): 153-163.
  1. 13.   Natural inhibitors of carcinogenesis
  2. Kinghorn, A. D.; Su, B. N.; Jang, D. S.; Chang, L. C.; Lee, D.; Gu, J. Q.; Carcache-Blanco, E. J.; Powlus, A. D.; Lee, S. K.; Park, E. J.; Cuendet, M.; Gills, J. J.; Bhat, K.; Park, H. S.; Mata-Greenwood, E.; Song, L. L.; Jong, M. H.; Pezzuto, J. M.
  3. Planta Medica. 2004, AUG; 70(8): 691-705.
  1. 14.   Tumor endothelial markers: new targets for cancer therapy
  2. Nanda, A.; St Croix, B.
  3. Current Opinion in Oncology. 2004, JAN; 16(1): 44-49.
  1. 15.   Proteomic investigation of natural killer cell microsomes using gas-phase fractionation by mass spectrometry
  2. Blonder, J.; Rodriguez-Galan, M. C.; Lucas, D. A.; Young, H. A.; Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2004 1698(1): 87-95.
  1. 16.   Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity
  2. Hakli, M.; Lorick, K. L.; Weissman, A. M.; Janne, O. A.; Palvimo, J. J.
  3. Febs Letters. 2004 560(1-3): 56-62.
  1. 17.   Caulibugulones A-F, novel cytotoxic isoquinoline quinones and iminoquinones from the marine bryozoan Caulibugula intermis
  2. Milanowski, D. J.; Gustafson, K. R.; Kelley, J. A.; McMahon, J. B.
  3. Journal of Natural Products. 2004 67(1): 70-73.
  1. 18.   Proteomic analysis of detergent-resistant membrane rafts
  2. Blonder, J.; Hale, M. L.; Lucas, D. A.; Schaefer, C. F.; Yu, L. R.; Conrads, T. R.; Issaq, H. J.; Stiles, B. G.; Veenstra, T. D.
  3. Electrophoresis. 2004 25(9): 1307-1318.
  1. 19.   Development of a two-dimensional protein-peptide separation protocol for comprehensive proteome measurements
  2. Janini, G. M.; Conrads, T. P.; Veenstra, T. D.; Issaq, H. J.
  3. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 2003 787(1): 43-51.
  1. 20.   Methods for fractionation, separation and profiling of proteins and peptides
  2. Issaq, H. J.; Conrads, T. P.; Janini, G. M.; Veenstra, T. D.
  3. Electrophoresis. 2002 23(17): 3048-3061.
  1. 21.   Nanoparticle Size Distribution and Stability Assessment Using Asymmetric-Flow Field-Flow Fractionation
  2. Hansen,Matthew; Clogston,Jeffrey
  3. Methods in Molecular Biology (Clifton, N.J.). 2024 2789: 21-29.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel